FDA Inspection 1210145 — Xytex Laboratories

Xytex Laboratories — FEI 1000507143

The FDA completed an inspection of Xytex Laboratories on July 11, 2023 in Augusta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 11, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Augusta, GA (United States)